Shilpa Pharma Receives EcoVadis Gold Medal for Sustainability

Filed: November 10, 2025

Filing Summary

Shilpa Pharma Lifesciences Limited, a subsidiary of Shilpa Medicare Limited, has been awarded the Gold Medal by EcoVadis for excellence in sustainability. The company achieved a score of 82 out of 100, placing it in the 98th percentile globally among over 130,000 companies evaluated. This recognition highlights Shilpa Pharma’s commitment to Environmental, Social, and Governance (ESG) practices. EcoVadis assesses companies on four pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. The award reinforces Shilpa Pharma’s position as a trusted global Contract Development and Manufacturing Organization (CDMO).

Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited, has been awarded the Gold Medal by EcoVadis for excellence in sustainability. The award was announced on 10th November 2025. Shilpa Pharma achieved a score of 82 out of 100, placing it in the 98th percentile among over 130,000 companies evaluated globally by EcoVadis.

EcoVadis is recognized as a trusted provider of business sustainability ratings. The assessment covers four key pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. This recognition positions Shilpa Pharma among the top companies globally for sustainable business operations.

Mr. Keshav Bhutada, Executive Director and CEO of Shilpa Pharma Lifesciences, stated that sustainability and innovation are integral to the company’s growth strategy as a CDMO. The EcoVadis Gold Medal reflects the company’s efforts in responsible manufacturing and ethical governance.

Shilpa Pharma’s achievement further strengthens its credentials with global customers, investors, and partners. The company is recognized as a trusted global CDMO partner with sustainability at the core of its operations.

Shilpa Medicare Limited focuses on developing and manufacturing pharmaceutical products. The company prioritizes sustainability and innovation in its operations, aiming to enhance its position as a global CDMO partner. Shilpa Medicare is committed to maintaining high standards in Environmental, Social, and Governance (ESG) practices.

Recent Filings from Shilpa Medicare

Date of Filing
Postings
Filing Type

Related Filings from Pharmaceuticals & Biotechnology

Date of Filing
Postings
Sub-Industry
Filing Type
Mar 21, 2026
Pharmaceuticals
Business Update
Mar 21, 2026
Pharmaceuticals
New Product
Mar 18, 2026
Pharmaceuticals
MOU, Agreements
Mar 18, 2026
Pharmaceuticals
Acquisitions & Mergers
Mar 17, 2026
Pharmaceuticals
Acquisitions & Mergers
Mar 16, 2026
Pharmaceuticals
MOU, Agreements
Mar 16, 2026
Pharmaceuticals
Pharma Regulations
Mar 14, 2026
Pharmaceuticals
Pharma Regulations
Mar 14, 2026
Pharmaceuticals
Pharma Regulations
Mar 13, 2026
Pharmaceuticals
Pharma Regulations
Mar 13, 2026
Pharmaceuticals
Pharma Regulations
Dec 11, 2025
Pharmaceuticals
Company Update
Nov 11, 2025
Pharmaceuticals
Company Update